Mizuho Securities Downgrades Eagle Pharmaceuticals (EGRX) to Neutral; Stock to Plateau Post-Analyst Day
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 3/28/2024
Go back to Mizuho Securities Downgrades Eagle Pharmaceuticals (EGRX) to Neutral; Stock to Plateau Post-Analyst Day
November 14, 2016 6:56 AM EST
RBC Capital analyst, Randall Stanicky, reiterated his Outperform rating on shares of Eagle Pharmaceuticals (NASDAQ: EGRX) after the analyst day and is confident in the BENDEKA base and encouraged on the potential for value creation.
Pipeline was the focus at the analyst... More